AAA
LIAN

Affinity Asset Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

Affinity Asset Advisors’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,779,694
Closed -$16.9M – 119
2023
Q4 		$16.9M Buy
3,779,694
+3,107,337
+462% +$10.7M 3.09% 9
2023
Q3 		$1M Sell
672,357
-128,319
-16% -$244K 0.28% 59
2023
Q2 		$1.83M Buy
800,676
+150,676
+23% +$346K 0.64% 39
2023
Q1 		$1.27M Hold
650,000
– – 0.42% 51
2022
Q4 		$1.07M Buy
650,000
+100,000
+18% +$156K 0.42% 51
2022
Q3 		$1.09M Buy
550,000
+100,000
+22% +$239K 0.31% 49
2022
Q2 		$972K Buy
450,000
+125,000
+38% +$424K 0.41% 42
2022
Q1 		$1.21M Buy
325,000
+252,594
+349% +$1.04M 0.19% 45
2021
Q4 		$446K Buy
+72,406
New +$827K 0.16% 51

Other funds holding LIAN

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Affinity Asset Advisors's LIAN Position: Q1 2024 in Review

Affinity Asset Advisors sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 3,779,694 shares — an estimated $16.9M sold.

Affinity Asset Advisors first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $16.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

  • Affinity Asset Advisors reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 3,779,694 LianBio American Depositary Shares shares in Q1 2024, an estimated $16.9M.
  • Affinity Asset Advisors first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Affinity Asset Advisors's LianBio American Depositary Shares position peaked at $16.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Affinity Asset Advisors's 13F filing for Q1 2024, filed 14 May 2024.